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Abstract
Objective: Adenoviruses play an important role in the etiology of severe acute lower 
respiratory infection, especially in young children. The aim of the present study was to 
evaluate the Human Adenovirus (HAdV) detection by different methods (Direct Fluores-
cence Assay – DFA and Nested Polymerase Chain Reaction – nested PCR), among samples 
collected from different groups of pediatric patients.
Methods: Collection of samples was made in children with congenital heart disease (CHD 
– 123 nasal aspirates collected in the years of 2005, 2007 and 2008) and in community 
children (CC – 165 nasal aspirates collected in 2008). Children were eligible if they pre-
sented acute respiratory infection (ARI) of probable viral etiology, within up to 7 days of 
symptoms’ onset. All studied samples were evaluated by DFA and nested PCR assay.
Results: Of the 290 samples included during the study period, 43 (14.8%) were positive 
on at least one test: 17/165 (10.3%) of the CC and 26/125 (20.8%) of the CHD children. 
The nested PCR detection rates in the community children were 15/165 (9.1%), and for 
children with CHD, 24/125 (19.2%). Molecular method showed higher detection rates 
when compared to the DFA test (p<0.001). Univariate analysis showed that children with 
congenital heart disease presented a significantly higher chance for acquiring the HAdV 
(Odds Ratio 2.3; 95% CI: 1.18-4.43).
Conclusions: Based on data obtained in the present evaluation, we suggest that a routine 
surveillance should be performed in high risk patients by molecular methods, thus im-
proving diagnostic flow and efficiency.
© 2015 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
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Aplicação de teste molecular para detecção de adenovírus em pacientes pediátricos 
distintos
Resumo
Objetivo: Os adenovírus desempenham um papel importante na etiologia da infecção 
aguda grave do trato respiratório inferior, especialmente entre crianças. O objetivo do 
estudo foi avaliar a detecção do adenovírus humano (HAdV) por diferentes métodos (imu-
nofluorescência direta – DFA e reação em cadeia da polimerase nested – nested PCR) em 
amostras coletadas de diferentes populações de pacientes pediátricos.
Métodos: O material foi coletado de crianças portadoras de doença cardíaca congênita 
(DCC – 123 aspirados nasais coletados em 2005, 2007 e 2008) e de crianças da comunidade 
(CC – 165 aspirados nasais coletados em 2008). As crianças eram consideradas elegíveis 
se apresentas sem infecção respiratória aguda (IRA) de provável etiologia viral, com até 
sete dias de início dos sintomas. Todas as amostras coletadas no estudo foram avaliadas 
por meio de DFA e nested PCR.
Resultados: De 209 amostras incluídas, 43 (14,8%) foram positivas em pelo menos um dos 
testes feitos: 17/165 (10,3%) das crianças da comunidade e 26/125 (20,8%) das crian-
ças cardiopatas. As taxas de detecção por nested PCR foram 15/165 (9,1%) em crianças 
da comunidade e 24/125(19,2%) em crianças cardiopatas. O método molecular mostrou 
maiores taxas de detecção quando comparado com a DFA (p<0,001). A análise univariada 
mostrou que as crianças portadoras de cardiopatia congênita apresentaram chance signi-
ficativamente maior de adquirir HAdV (odds ratio 2,3; IC 95%: 1,18-4,43).
Conclusões: Baseado nos resultados obtidos na presente avaliação, recomenda-se a vi-
gilância de rotina em pacientes de risco (DCC) por métodos moleculares, que melhora o 
fluxo diagnóstico e a eficiência da detecção.
© 2015 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Introduction
Adenoviruses play an important role in the etiology of 
severe acute lower respiratory infection, especially in 
young children.1 Human adenoviruses (HAdV) spread rapidly 
in closed environments, which often cause epidemic dis-
ease in crowded communities. Furthermore, adenovirus 
infection is difficult to clinically distinguish from other viral 
or bacterial respiratory infections.2 This combination of 
factors indicates that improved clinical microbiological 
methods are necessary for detection of the acute respira-
tory disease caused by adenoviruses.
Prior to the advent of PCR, DFA and viral isolation were 
the most sensitive methods that were available for respira-
tory viruses detection.3,4 However, a significant number of 
specimens in patients with clinically compatible viral respi-
ratory infection were incorrectly determined to be nega-
tive by DFA and viral culture, implying a failure to identify 
the causative virus in a significant percentage of cases.5-7 
Molecular methods demonstrate greater sensitivity when 
compared to conventional assays for detecting adenovirus 
in respiratory samples.8,9
In the pediatric population HAdV is the second most com-
mon detected pathogen10 and the virus is responsible for 
5%–15% of respiratory disease.10,11 Clinical samples from 
children often present higher viral loads when compared to 
adults patients.12 Brazilian studies described an incidence 
ranging from 3% to 7.1%, depending on the technique 
used.13-16 Other group at risk to acquired HAdV respiratory 
infection was the congenital heart disease children, but 
there are no published data.
In this context, the aim of the present study was to 
assess HAdV occurrence by two different methods (Direct 
Fluorescence Assay – DFA and Nested Polymerase Chain 
Reaction – nested PCR) in samples collected from different 
pediatric populations.
Method
This cross sectional study included two different popula-
tions assessed from 2005 to 2008:
1.  Congenital heart disease children (CHD): during 2005, 
2007, and 2008, 123 outpatients with CHD assisted in the 
Congenital Heart Disease Pediatric Service were includ-
ed. During the year of 2006 the congenital heart disease 
ward underwent a structural and administrative reform, 
preventing sample collection. Among these patients, 
49.7% were male, the mean and median age 3.9 and 
2.9 years old, ranging from1 year and 6 month to 11 years 
old.
2.  Community children (CC): in 2008, 165 outpatients seen 
in a primary care facility by a pediatrician were includ-
ed. Among these patients, 47.2% were male, the mean 
and median age 3.9 and 3.0 years old, ranging from 
7 months to 11 years old.
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For both groups, children were eligible if they presented 
acute respiratory infection (ARI) of probably viral etiology 
and preferably up to 7 days of symptoms until sample col-
lection. In the community children group, patients were 
included when parents or guardians sought medical care 
due to acute respiratory infection. Among CHD group, the 
inclusion of patients was defined by a physician during a 
previous routine visit. The CHD population was considered 
at risk for viral respiratory infection complications; there-
fore, samples of children with more than 7 days of symp-
toms were collected (ranged from 1 to 60 days). Respiratory 
symptoms assessed were: coryza, cough, sore throat, or 
nasal congestion; and systemic symptoms were: fever, 
headache, malaise, chills, or fatigue. Written consent was 
obtained from all participants’ legal representative before 
enrollment.
All nasal samples were maintained at 4 ºC and transport-
ed immediately to the laboratory. An aliquot (1 mL) was 
separated for molecular analysis and stored at –70 ºC. The 
remaining specimen volume was evaluated on the same day 
by direct fluorescent assay (DFA), according to previous 
study.17 Afterwards, one aliquot from each stored sample 
had DNA extracted by QIamp DNA Blood extraction kit 
(Qiagen, USA), according to manufacturer’s instructions, 
follow by nested-PCR for detection of all adenovirus sero-
types, as previously described.18
All studied samples were evaluated by direct immunoflu-
orescence technique (DFA). The tests were performed using 
the kit “Simulfluor Respiratory Screen and Panel” (Chemicon 
Int., EUA), in accordance with the manufacturer’s instruc-
tions.
The primers used for detection target the region of HAdV 
Hexon gene. The outer primer pair, hex1deg (5′-GCC SCA 
RTG GKC WTA CAT GCA CAT C-3′) and hex2deg (5′-CAG CAC 
SCC ICG RAT GTC AAA-3’), resulted in a 301 bp product. The 
nested primer pair, nehex3deg (5′-GCC CGY GCM ACI GAI 
ACS TAC TTC-3′) and nehex4deg (5′-CCY ACR GCC AGI GTR 
WAI CGM RCY TTG TA-3′), produced an amplicon of 171 bp. 
For the first amplification reaction, 5 µL of extracted DNA 
were placed in a tube with a reaction mixture consisting of 
2.5 µL of 103 buffer (200mM Tris-HCl, pH 8.4, 500mM KCl), 
3.5 µM of MgCl2, 0.5 µM of primers Hex1deg and Hex2deg, 
1µL of dNTPs mixture containing 20 mM of each nucleotide, 
2,5U of Platinum® TaqDNA Polymerase (Invitrogen, Brazil) 
and autoclaved MilliQ water to a final volume of 25 µL. For 
the second amplification reaction, 2 µL of first reaction 
amplicon were placed in a tube with a reaction mixture 
consisting of 2.5 µL of 103 buffer (200 mM Tris-HCl, pH 8.4, 
500 mM KCl), 3.5 µM of MgCl2, 0.5 µM of primers Nehex3deg 
and Nehex4deg, 1µL of dNTPs mixture containing 20 mM of 
each nucleotide, 2,5U of Platinum® TaqDNA Polymerase 
(Invitrogen, Brazil) and autoclaved MilliQ water to a final 
volume of 25 µL. Positive controls (Adenovirus Serotype 3) 
and redundant negative control (autoclaved MilliQ water) 
were included in each series. Positive results were consid-
ered when amplicon were visualized after 2% agarose gel 
electrophoresis. The sensibility of the reaction were stan-
dardized and showed a detection limit of 10–4 TCID50/mL.
Association between different categorical variables 
(response variable: presence or absence of HAdV; indepen-
dent variable: community children and congenital heart 
disease children) was tested using the chi-square test and 
univariate Odds Ratio (SPSS, version 11.5). p<0.05 was con-
sidered to be statistically significant. To compare used 
methods, the Kappa test was conducted (R software version 
2.11.1) and the interpretation of the coefficients was per-
formed using the classification of Altman.19
The present study was approved by the Institutional 
Review Board of São Paulo Hospital and the Federal 
University of São Paulo (1654/09).
Results
Samples from 290 symptomatic patients were analyzed 
(48.6% (141/290) females and 51.4% (149/290) males), 
being 56.9% (165/290) from the community and 43.1% 
(125/290) from CHD children. The time between onset of 
symptoms and sample collection ranged from 1 to 60 days.
Among the 290 samples included during the study period, 
41 (14.1%) were positive for at least one test: 17/165 
(10.3%) children from community, 26/125 (20.8%) CHD chil-
dren. Table 1 show the differential detection between 
assays according to different studied populations. Overall, 
4/290 (0.7% of samples were DFA positive and 39/290 
(13.40%) were nested-PCR positive. Nested-PCR presented 
a higher detection, statistically significant, among all stud-
ied populations when compared to DFA (p<0.001). Comparing 
the children groups by molecular methods, CHD presented 
higher detection rate (p=0.02).
Analysis of the length of time between symptoms onset 
and the sample collection day showed a statistical differ-
ence between DFA and nested-PCR (Table 2). Among commu-
nity children, the mean ± standard deviation, median and 
range since symptoms onset were: 3.2±2.72; 3; 1-20 days; 
and among CHD children the mean ± standard deviation, 
median and range since symptoms onset were: 6.5±7.1; 5; 
1-60 days. Nested-PCR compared to DFA detected a higher 
Table 1 HAdV detection by DFA and nested-PCR among different studied populations.
Nº DFA nested-PCR p Global positivity
Positive Negative Positive Negative
Community 165 2 (1.2%) 163 (98.8%) 15 (9.1%) 150 (90.9%) <0.001 17 (10.3%)
CHD 125 2 (1.6%) 123 (98.4%) 24 (19.2%) 101 (80.8%) <0.001 26 (20.8%)
Total 290 4 (1.4%) 286 (98.6%) 39 (13.4%) 251 (86.5%) 43 (14.8%)
CHD, children with congenital heart disease; DFA, direct fluorescence assay; PCR, Polymerase Chain Reaction.
Application of molecular assay for adenovirus detection 139
number of cases both for samples collected within 5 days of 
symptoms onset, and >5 days of symptoms onset.
Table 3 shows the agreement between the evaluated 
tests. The general agreement was low, mainly among com-
munity children. The concordance regarding negative 
results was high for both studied populations.
Table 4 shows the result of the univariate Odds Ratio 
analysis of HAdV occurrence among different studied popu-
lations. The response variable was the presence or absence 
of HAdV, and the independent variable was the studied 
group: community children and CHD children. CHD children 
presented approximately two times more chance to 
acquired HAdV infection when compared to community 
children.
Discussion
Among community children, the adenovirus detection rate 
was similar to that described in the national literature, 
with rates ranging from 6% to 7.1%.13-16 A recent Brazilian 
study evaluating 1,121 samples collected from hospitalized 
infants found adenovirus occurrence in 15.8%, which cor-
roborates the findings of the present study.10 International 
studies report HAdV occurrence ranging from 2%-3.8% 
among pediatric populations, which is slightly lower when 
compared to our results.20-22 Studies with CHD children 
demonstrate respiratory viruses circulation, with relative 
high occurrence rates, showing that these agents must be 
considered in clinical and diagnostic practice.22 The present 
study is the first to describe HAdV respiratory infection in 
Brazilian children with congenital heart disease. The HAdV 
detection rate in CHD children was higher (20.8%) when 
compared to community children (10.3%). It is noteworthy 
that, among CHD children sample collection was accom-
plished during routine consultation. If the patient present-
ed respiratory infection during the scheduled appointment, 
the sample was collected. Therefore the rate found could 
be underestimated, because probable cases may have been 
lost due to lack of active demand from patients. One 
hypothesis for the higher detection can be related to 
comorbidities presence among this children.23
When evaluating the two tests used in this study some 
important questions for both clinicians and hospital admin-
istrators are raised: Which is the best test? Up to which day 
is ideal to collect the sample? Is there a need to repeat the 
test? Which is the ideal number of samples for laboratory 
routine flow? What is the impact of negative and positive 
tests for high-risk patients? Some of these aspects could be 
evaluated in the present study.
The analysis of the association between patient´s symp-
tom onset and laboratorial test results showed that the 
molecular method was always more sensible than the DFA, 
and this difference was more evident after the fifth day 
of symptoms (p<0.001). Lower detection by DFA was relat-
ed to low viral load in respiratory samples.24 The higher 
detection rates among patients with more than five days 
of symptom were expected due to higher nested-PCR sen-
sibility.25,26 The success of DFA test depend on some key 
factors as good sample collection and experienced labora-
tory staff,10 while nested-PCR, based on nucleic acid 
amplification, can detect a very low number of viral par-
ticles.10,26
Univariate analysis showed that CHD children have a 
higher risk of acquiring HAdV (Odds Ratio: 2.29), when 
compared to community children. Utokaparch (2011)27 
described that pediatric patients with lower respiratory 
infection presented higher viral load when compared to 
patients with upper respiratory infection. Echavarria et 
al.28 described that children are 2 to 3.5 times more likely 
to become infected by HAdV than adults. These data cor-
roborates the results of the present study.
One of the study limitations was the lack of another 
respiratory viruses analysis. Among HAdV negative samples, 
others virus could be present. As a result of the high sensi-
tivity of the molecular methods, viral infections could be 
detected weeks after the symptoms resolution29,30 but, in 
the present study, the included samples were collected 
from children presenting acute respiratory infection, 
Table 2 Time of symptoms onset according to evaluated test.
 ≤5 days >5 days
Positive Negative Positive Negative
% % % %
DFA  3 (1.4) 211 (98.6)  1 (1.3) 75 (98.7)
Nested-PCR 24 (11.2) 190 (88.8) 15 (19.7) 61 (80.3)
p <0.001 <0.001
Total 214 76
DFA, direct fluorescence assay; PCR, Polymerase Chain Reaction.
Table 3 Agreement assessment between the tests.
Collected 
samples
DFA positive Nested-PCR 
postive
Concordancea Positivity 
concordance
Negativity 
concordanceb
Children
Community 165 2 (1.2%) 15 (9.1%) 64.9% 0 98.7%
CHD 125 2 (1.6%) 24 (19.2%) 79.2% 0 98.0%
Total 290 4 (1.4%) 39 (13.5%)
CHD, children with congenital heart disease; PCR, Polymerase Chain Reaction.
a Concordance calculated by method to compare two tests when gold standard method was not known.
b Higher values of negativity concordance show that the methods presented similar performance to detected negative cases.
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decreasing the chance of a past infection detection. 
Another study limitation was the lack of sample collection 
during 2006; however the main idea of the study was to 
understand the occurrence of the virus in the community 
(community children), and in a population with at high risk 
of complications after a viral respiratory infection (CHD 
children). Some studies described an occurrence of adeno-
virus during different years, and throughout the year,31,32 
with similar occurrence patterns; therefore the collection 
of samples during different years apparently did not com-
promise the purpose of the study.
Three parameters can indicate the validity of the diag-
nostic test choice, the cost per sample, the turnaround 
time (time to provide the result) and the test reliability. In 
a study published in 2009 Mahony et al.33 compared the cost 
of DFA versus molecular technique for diagnosing respirato-
ry virus infection, and they described that molecular test 
was slightly more expensive but, at the same time, was 
highly cost-effective due to reduction in hospitalization 
time. Different studies described the turnaround time of 
DFA and PCR, with both tests presenting the ability to pro-
vide results in one day.34,35 Gharabaghi et al.34 compared the 
sensitivity and specificity of DFA and commercial molecular 
assay. This study showed lower sensitivity of DFA test in 
comparison to molecular testing for all surveyed virus, with 
adenovirus presenting the lowest sensitivity (38.1%)34
We suggest that routine surveillance should be performed 
in high-risk patients by molecular methods, improving diag-
nostic flow and efficiency. Our results also demonstrated 
that in samples with more than five days of symptom onset 
nested-PCR might be the best option.
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